PHARMACIE DELAROQUE CORDESSE : revenue, balance sheet and financial ratios

PHARMACIE DELAROQUE CORDESSE is a French company founded 33 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ALES (30100), this company of category PME shows in 2017 a revenue of 1.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DELAROQUE CORDESSE (SIREN 388684359)
Indicator 2020 2019 2018 2017 2015
Revenue N/C N/C N/C 1 875 490 € 1 952 837 €
Net income 116 667 € 97 873 € 122 119 € 111 517 € 128 623 €
EBITDA N/C N/C N/C 177 922 € 202 187 €
Net margin N/C N/C N/C 5.9% 6.6%

Revenue and income statement

In 2020, PHARMACIE DELAROQUE CORDESSE generates positive net income of 117 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2020: 129 k€ -> 117 k€.

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

116 667 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 7%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 83%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

7.448%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

83.321%

Asset age ratio (2020) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

31.0%

Solvency indicators evolution
PHARMACIE DELAROQUE CORDESSE

Sector positioning

Debt ratio
7.45 2020
2018
2019
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Excellent

In 2020, the debt ratio of PHARMACIE DELAROQUE CORDESSE (7.45) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
83.32% 2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Excellent

In 2020, the financial autonomy of PHARMACIE DELAROQUE CORDESSE (83.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 378.56. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2020) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

378.563

Liquidity indicators evolution
PHARMACIE DELAROQUE CORDESSE

Sector positioning

Liquidity ratio
378.56 2020
2018
2019
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Excellent

In 2020, the liquidity ratio of PHARMACIE DELAROQUE CORDESSE (378.56) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2020) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2020) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2020) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2020) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DELAROQUE CORDESSE

Positioning of PHARMACIE DELAROQUE CORDESSE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 180 transactions of similar company sales in 2020, the value of PHARMACIE DELAROQUE CORDESSE is estimated at 1 648 814 € (range 1 099 406€ - 2 224 696€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
180 transactions
1099k€ 1648k€ 2224k€
1 648 814 € Range: 1 099 406€ - 2 224 696€
NAF 5 année 2020

Valuation method used

Net Income Multiple
116 667 € × 14.1x = 1 648 815 €
Range: 1 099 407€ - 2 224 696€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DELAROQUE CORDESSE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DELAROQUE CORDESSE

What is the revenue of PHARMACIE DELAROQUE CORDESSE ?

The revenue of PHARMACIE DELAROQUE CORDESSE in 2017 is 1.9 M€.

Is PHARMACIE DELAROQUE CORDESSE profitable?

Yes, PHARMACIE DELAROQUE CORDESSE generated a net profit of 117 k€ in 2020.

Where is the headquarters of PHARMACIE DELAROQUE CORDESSE ?

The headquarters of PHARMACIE DELAROQUE CORDESSE is located in ALES (30100), in the department Gard.

Where to find the tax return of PHARMACIE DELAROQUE CORDESSE ?

The tax return of PHARMACIE DELAROQUE CORDESSE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DELAROQUE CORDESSE operate?

PHARMACIE DELAROQUE CORDESSE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.